IMC Chicago
DGX icon

IMC Chicago’s Quest Diagnostics DGX Stock Holding History

IMC Chicago’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.1M Buy
33,500
+16,900
+102% +$3.32M ﹤0.01% 1819
2026
Q1 		$3.25M Sell
16,600
-700
-4% -$136K ﹤0.01% 2159
2025
Q4 		$3M Sell
17,300
-1,900
-10% -$346K ﹤0.01% 2110
2025
Q3 		$3.66M Sell
19,200
-7,600
-28% -$1.35M ﹤0.01% 1800
2025
Q2 		$4.81M Buy
26,800
+4,100
+18% +$712K ﹤0.01% 1413
2025
Q1 		$3.84M Buy
+22,700
New +$3.73M ﹤0.01% 1380

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

IMC Chicago's DGX Position: Q2 2026 in Review

IMC Chicago sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 5,227 shares — an estimated $1.03M sold.

IMC Chicago first reported a position in DGX in Q1 2026 and held it in 1 quarter. The position peaked at $1.02M in Q1 2026. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • IMC Chicago reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 5,227 Quest Diagnostics shares in Q2 2026, an estimated $1.03M.
  • IMC Chicago first reported a position in Quest Diagnostics in Q1 2026 and held it in 1 quarter.
  • IMC Chicago's Quest Diagnostics position peaked at $1.02M in Q1 2026.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.